ask="47.00"
ask_size="100"
average_daily_volume="378352"
bid="1.00"
bid_size="100"
book_value="14.23"
change="-1.63"
change_from_200_day_moving_average="-6.75"
change_from_50_day_moving_average="-3.05"
change_from_52_week_high="-17.84"
change_From_52_week_low="12.79"
change_in_percent="-3.64%"
close="43.14"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-97.47M"
eps_estimate_current_year="-4.07"
eps_estimate_next_quarter="-1.10"
eps_estimate_next_year="-3.26"
ex_dividend_date="N/A"
float_shares="24516000"
high="46.50"
high_52_weeks="60.98"
last_trade_date="3/2/2017"
last_trade_price="43.14"
last_trade_size="17109"
last_trade_time="4:00pm"
low="43.03"
low_52_weeks="30.35"
market_capitalization="1.19B"
moving_average_200_day="49.89"
moving_average_50_day="46.19"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.50"
open="45.21"
pe_ratio="N/A"
peg_ratio="0.19"
percent_change_from_200_day_moving_average="-13.53%"
percent_change_from_50_day_moving_average="-6.61%"
percent_change_from_52_week_high="-29.26%"
percent_change_from_52_week_low="+42.14%"
previous_close="44.77"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.15"
price_per_sales="40.13"
revenue="30.69M"
shares_outstanding="27509000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="723376"
weeks_range_52="30.35 - 60.98"
